Product Name:Thymosin alpha1
Application: Prepared as a 28mer synthetic amino-terminal acylated peptide, Tα1 is in clinical trials worldwide for the treatment of some viral infections, either as a monotherapy or in combination with IFN-α Citation. Additional indications are some immunodeficiencies, malignancies and HIV/AIDS Citation.
Molar Mass:3108.3 g/mol
Target Indicators: Thymosin α1 is a naturally occurring thymic peptide first described and characterized by Goldstein and Goldstein and Garaci Citation.